S&P 500 7,680.39 â–ŧ 31.37 (-0.41%) DOW 53,221.10 â–ŧ 338.89 (-0.63%) NASDAQ 26,306.73 â–ŧ 95.70 (-0.36%) US Markets Closed â€ĸ 11:41 PM ET

NBTX

Nanobiotix S.A.

Price Chart

No historical data available

Latest Quote

$40.64

-0.59 (-1.43%)
Current Price
Previous Close $41.23
Open $41.23
Day High $41.41
Day Low $40.25
Volume 113,699
Fetched: 2026-09-01T00:27:24
Stock Information
Note: Financial values converted from EUR to USD
Shares Outstanding 50.81M
Total Debt $110.82M
Cash Equivalents $61.33M
Revenue $37.89M
Net Income $-27.86M
Sector Healthcare
Industry Biotechnology
Market Cap $2.06B
EPS (TTM) $-0.58
Exchange NMS
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Nanobiotix S.A.

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.

📰 Latest News
No news articles available at the moment. Check back later for updates on NBTX.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $34,464,600 $-13,498,432 $34,947,102 $0
Operating Revenue $26,371,354 $-20,386,003 $34,589,004 $0
Expenses
Interest Expense $12,085,805 $9,401,233 $9,280,317 $6,786,421
Total Expenses $47,042,208 $66,017,910 $66,080,694 $54,299,504
Other Income Expense $-3,760,028 $3,470,527 $-7,350,309 $2,448,553
Net Non Operating Interest Income Expense $-11,517,266 $-3,051,971 $-7,534,008 $-14,458,785
Total Other Finance Cost $576,677 $-3,292,641 $-331,357 $7,970,004
Interest Expense Non Operating $12,085,805 $9,401,233 $9,280,317 $6,786,421
Operating Expense $47,042,208 $66,017,910 $66,080,694 $54,299,504
Other Operating Expenses $-469,713 $-973,143 $520,870 $398,791
General And Administrative Expense $23,511,222 $23,321,709 $25,184,283 $20,323,220
Rent Expense Supplemental - - - -
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-27,858,391 $-79,214,051 $-46,157,427 $-66,319,038
Net Interest Income $-11,517,266 $-3,051,971 $-7,534,008 $-14,458,785
Interest Income $1,145,216 $3,056,622 $1,414,952 $297,640
Normalized Income $-25,038,370 $-81,816,947 $-40,644,696 $-68,155,453
Net Income From Continuing And Discontinued Operation $-27,858,391 $-79,214,051 $-46,157,427 $-66,319,038
Total Operating Income As Reported $2,432,276 $-79,516,342 $-31,134,754 $-54,298,342
Net Income Common Stockholders $-27,858,391 $-79,214,051 $-46,157,427 $-66,319,038
Net Income $-27,858,391 $-79,214,051 $-46,157,427 $-66,319,038
Net Income Including Noncontrolling Interests $-27,858,391 $-79,215,214 $-46,157,427 $-66,321,363
Net Income Continuous Operations $-27,858,391 $-79,215,214 $-46,157,427 $-66,321,363
Pretax Income $-27,854,903 $-79,097,786 $-46,017,909 $-66,309,737
Interest Income Non Operating $1,145,216 $3,056,622 $1,414,952 $297,640
Operating Income $-12,577,608 $-79,516,342 $-31,133,592 $-54,299,504
Depreciation Amortization Depletion Income Statement $401,116 $370,887 $313,917 $389,490
Depreciation And Amortization In Income Statement $401,116 $370,887 $313,917 $389,490
Amortization Of Intangibles Income Statement $1,163 $1,163 $0 $1,163
Depreciation Income Statement $399,954 $369,724 $313,917 $388,327
Special Income Charges - - $0 $0
Per Share
Diluted EPS $-0.58 $-1.67 $-1.26 $-1.91
Basic EPS $-0.58 $-1.67 $-1.26 $-1.91
Other
Tax Effect Of Unusual Items $-940,007 $867,632 $-1,837,577 $612,138
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-10,270,900 $-71,282,415 $-27,628,185 $-60,227,885
Total Unusual Items $-3,760,028 $3,470,527 $-7,350,309 $2,448,553
Total Unusual Items Excluding Goodwill $-3,760,028 $3,470,527 $-7,350,309 $2,448,553
Reconciled Depreciation $1,738,170 $1,884,665 $1,759,098 $1,743,983
EBITDA (Bullshit earnings) $-14,030,928 $-67,811,888 $-34,978,494 $-57,779,333
EBIT $-15,769,098 $-69,696,553 $-36,737,592 $-59,523,316
Diluted Average Shares $55,597,757 $54,953,137 $42,934,733 $40,438,438
Basic Average Shares $55,597,757 $54,953,137 $42,934,733 $40,438,438
Diluted NI Availto Com Stockholders $-27,858,391 $-79,214,051 $-46,157,427 $-66,319,038
Tax Provision $3,488 $117,428 $139,519 $11,627
Gain On Sale Of Security $-3,760,028 $3,470,527 $-7,350,309 $2,448,553
Other Taxes $-3,275,201 $-3,836,763 $-4,579,700 $-4,756,424
Amortization $1,163 $1,163 $0 $1,163
Research And Development $26,874,784 $47,135,221 $44,641,324 $37,944,428
Selling General And Administration $23,511,222 $23,321,709 $25,184,283 $20,323,220
Other Gand A $9,296,594 $9,386,119 $11,497,501 $9,059,412
Salaries And Wages $14,214,627 $13,935,590 $13,686,782 $11,263,807
Rent And Landing Fees - - - -
Fetched: 2026-09-01
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-98,236,260 $-76,398,099 $-2,153,238 $-31,445,183
Total Assets $78,781,543 $78,383,915 $109,169,873 $69,490,763
Total Non Current Assets $5,824,905 $6,918,963 $7,624,695 $8,617,603
Other Non Current Assets $29,066 - - -
Non Current Prepaid Assets $475,526 $472,038 $347,634 $338,333
Goodwill And Other Intangible Assets $11,627 $8,139 $9,301 $1,163
Other Intangible Assets $11,627 $8,139 $9,301 $1,163
Current Assets $72,956,639 $71,463,789 $101,545,177 $60,874,322
Other Current Assets $2,325 $-1,163 $1,163 $1,163
Prepaid Assets $2,695,036 $3,714,685 $2,976,398 $3,465,876
Receivables $8,929,195 $9,923,266 $11,039,415 $9,287,293
Other Receivables $1,657,947 $1,261,481 $4,046,041 $3,186,839
Taxes Receivable $4,787,816 $5,200,558 $5,941,170 $5,983,026
Accounts Receivable $2,483,432 $3,461,226 $1,052,203 $117,428
Cash Cash Equivalents And Short Term Investments $61,330,083 $57,827,002 $87,528,202 $48,119,990
Cash And Cash Equivalents $61,330,083 $57,827,002 $87,528,202 $48,119,990
Cash Equivalents $60,388,332 $51,653,300 $0 $3,270,550
Cash Financial $941,751 $6,172,539 $87,528,202 $44,850,602
Investmentin Financial Assets - - $0 $0
Debt
Net Debt $45,890,017 - - $7,266,597
Total Debt $110,823,169 $59,181,495 $58,789,680 $61,816,073
Long Term Debt And Capital Lease Obligation $105,813,286 $53,456,579 $52,950,824 $56,514,363
Long Term Debt $103,617,030 $50,004,655 $48,436,232 $51,203,353
Current Debt And Capital Lease Obligation $5,009,883 $5,724,916 $5,838,856 $5,301,710
Current Debt $3,603,070 $4,258,807 $4,444,832 $4,183,235
Other Current Borrowings $3,603,070 $4,258,807 $4,444,832 $4,183,235
Liabilities
Total Liabilities Net Minority Interest $177,006,177 $154,773,876 $111,313,810 $100,934,783
Total Non Current Liabilities Net Minority Interest $110,145,341 $86,252,768 $53,328,687 $56,828,280
Other Non Current Liabilities $3,742,588 $32,293,922 $2,325 -
Current Liabilities $66,860,836 $68,521,108 $57,985,123 $44,106,503
Other Current Liabilities $362,749 $9,109,407 - -
Current Deferred Liabilities $42,107,898 $21,114,988 $21,192,886 $19,268,691
Payables And Accrued Expenses $19,243,113 $32,062,553 $30,069,762 $19,155,914
Payables $16,288,805 $13,983,259 $16,851,530 $12,884,549
Other Payable $712,708 $781,305 $488,315 $567,376
Total Tax Payable $7,925,823 $7,988,607 $8,579,236 $7,667,714
Accounts Payable $7,650,274 $5,213,348 $7,783,979 $4,649,460
Equity
Common Stock Equity $-98,224,633 $-76,389,961 $-2,143,937 $-31,444,021
Total Equity Gross Minority Interest $-98,224,633 $-76,389,961 $-2,143,937 $-31,444,021
Stockholders Equity $-98,224,633 $-76,389,961 $-2,143,937 $-31,444,021
Gains Losses Not Affecting Retained Earnings $-437,327,091 $-362,177,683 $-320,976,657 $-263,436,831
Other Equity Adjustments $-437,327,091 $-362,177,683 $-320,976,657 $-263,436,831
Retained Earnings $-27,858,391 $-79,214,051 $-46,157,427 $-66,319,038
Other
Treasury Shares Number $25,716 $25,716 $25,716 $25,716
Ordinary Shares Number $56,258,521 $55,115,378 $54,774,112 $40,522,912
Share Issued $56,284,237 $55,141,094 $54,799,828 $40,548,628
Tangible Book Value $-98,236,260 $-76,398,099 $-2,153,238 $-31,445,183
Invested Capital $8,995,466 $-22,126,499 $50,737,128 $23,942,567
Working Capital $6,095,803 $2,942,681 $43,560,055 $16,767,819
Capital Lease Obligations $3,603,070 $4,918,033 $5,908,616 $6,429,485
Total Capitalization $5,392,397 $-26,385,306 $46,292,295 $19,759,332
Treasury Stock $265,085 $265,085 $265,085 $265,085
Additional Paid In Capital $365,537,758 $363,612,400 $363,611,238 $297,360,796
Capital Stock $1,688,176 $1,654,459 $1,643,995 $1,216,138
Common Stock $1,688,176 $1,654,459 $1,643,995 $1,216,138
Employee Benefits $589,466 $502,267 $375,538 $313,917
Non Current Pension And Other Postretirement Benefit Plans $589,466 $502,267 $375,538 $313,917
Long Term Capital Lease Obligation $2,196,256 $3,451,924 $4,514,592 $5,311,011
Current Deferred Revenue $42,107,898 $21,114,988 $21,192,886 $19,268,691
Current Capital Lease Obligation $1,406,813 $1,466,109 $1,394,024 $1,118,475
Current Provisions $137,193 $509,243 $883,618 $380,188
Current Accrued Expenses $2,954,308 $18,079,295 $13,218,232 $6,271,364
Net PPE $5,308,685 $6,438,787 $7,267,760 $8,278,108
Accumulated Depreciation $-14,464,598 $-12,813,627 $-10,999,885 $-9,510,523
Gross PPE $19,773,284 $19,252,414 $18,267,645 $17,788,631
Construction In Progress $745,262 $454,598 $218,579 $399,954
Other Properties $3,010,115 $2,899,663 $2,706,662 $2,472,968
Machinery Furniture Equipment $5,476,108 $5,404,023 $5,113,359 $5,076,154
Buildings And Improvements $10,541,798 $10,494,129 $10,229,044 $9,838,392
Properties $0 $0 $0 $0
Investments And Advances - - $0 $0
Available For Sale Securities - - - -
Fetched: 2026-09-01
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-39,493,085 $-23,717,012 $-14,897,106 $-43,246,138
Operating Activities
Operating Cash Flow $-38,858,275 $-22,731,080 $-14,505,291 $-43,138,011
Cash Flow From Continuing Operating Activities $-38,857,113 $-22,731,080 $-14,506,454 $-43,140,336
Operating Gains Losses $177,886 $-3,488 $-27,904 $3,488
Investing Activities
Capital Expenditure $-634,810 $-985,932 $-391,815 $-108,127
Investing Cash Flow $-672,015 $-1,110,336 $-405,767 $160,446
Cash Flow From Continuing Investing Activities $-672,015 $-1,110,336 $-405,767 $159,284
Net Other Investing Changes - - - $1,163
Financing Activities
Issuance Of Capital Stock $1,784,676 $0 $69,938,385 $0
Financing Cash Flow $43,501,922 $-5,970,237 $54,378,565 $-6,570,167
Cash Flow From Continuing Financing Activities $43,503,085 $-5,970,237 $54,378,565 $-6,569,004
Net Other Financing Charges $-904,546 - $-3,243,809 $-1,163
Cash Dividends Paid $0 $0 $0 $0
Net Common Stock Issuance $1,784,676 $0 $69,938,385 $0
Common Stock Issuance $1,784,676 $0 $69,938,385 $0
Other
Repayment Of Debt $-5,515,638 $-4,830,834 $-4,377,398 $-5,505,174
Issuance Of Debt $49,916,293 $0 $174,398 $0
End Cash Position $61,330,083 $57,827,002 $87,528,202 $48,119,990
Beginning Cash Position $57,827,002 $87,528,202 $48,119,990 $97,571,221
Effect Of Exchange Rate Changes $-467,388 $109,290 $-59,295 $96,500
Changes In Cash $3,970,469 $-29,810,490 $39,467,507 $-49,547,731
Interest Paid Cff $-1,778,863 $-1,139,402 $-8,113,011 $-1,063,830
Net Issuance Payments Of Debt $44,400,655 $-4,830,834 $-4,203,000 $-5,505,174
Net Long Term Debt Issuance $44,400,655 $-4,830,834 $-4,203,000 $-5,505,174
Long Term Debt Payments $-5,515,638 $-4,830,834 $-4,377,398 $-5,505,174
Long Term Debt Issuance $49,916,293 $0 $174,398 $0
Net Investment Purchase And Sale $-37,205 $-124,404 $-13,952 $267,411
Net Intangibles Purchase And Sale $-9,301 $-2,325 $-10,464 $-1,163
Purchase Of Intangibles $-9,301 $-2,325 $-10,464 $-1,163
Net PPE Purchase And Sale $-625,509 $-983,607 $-381,351 $-106,964
Purchase Of PPE $-625,509 $-983,607 $-381,351 $-106,964
Taxes Refund Paid $-230,206 $-72,085 $-8,139 $0
Change In Working Capital $-3,954,192 $16,606,210 $11,533,544 $2,672,945
Change In Other Working Capital $-18,602 $14,176,260 $1,874,201 -
Change In Other Current Liabilities $203,465 $-260,435 $840,600 $1,418,440
Change In Payables And Accrued Expense $-6,291,129 $2,277,642 $10,086,037 $3,377,515
Change In Payable $-6,291,129 $2,277,642 $10,086,037 $3,377,515
Change In Receivables $2,152,076 $412,743 $-1,267,295 $-2,123,009
Changes In Account Receivables $976,631 $-2,406,697 $-937,100 $-117,428
Other Non Cash Items $-12,588,072 $33,258,926 $13,921,638 $14,715,732
Stock Based Compensation $4,114,638 $4,997,094 $3,746,076 $3,690,269
Provisionand Write Offof Assets $-261,598 $-305,778 $588,304 $354,610
Deferred Tax $3,488 $117,428 $139,519 $0
Deferred Income Tax $3,488 $117,428 $139,519 $0
Depreciation Amortization Depletion $1,738,170 $1,884,665 $1,759,098 $1,743,983
Depreciation And Amortization $1,738,170 $1,884,665 $1,759,098 $1,743,983
Net Income From Continuing Operations $-27,858,391 $-79,214,051 $-46,157,427 $-66,319,038
Proceeds From Stock Option Exercised - - $0 $0
Purchase Of Investment - - - -
Fetched: 2026-09-01